Aspirus At Home 311 Sixth Street, Calumet, MI, 49913 | |
(906) 337-5700 |
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
Name | Aspirus At Home |
---|---|
Location | 311 Sixth Street, Calumet, Michigan |
Hospice ID | 231560 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 300 |
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
NPI Number | 1053546309 |
Organization Name | Aspirus Vna Home Health Inc |
Address | 311 6th St Calumet, Michigan, 49913 |
Phone Number | (906)337-5700 |
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
NPI Number | 1548214315 |
Organization Name | Keweenaw Home Nursing, Inc. |
Address | 311 6th St Calumet, Michigan, 49913 |
Phone Number | (906)337-5700 |
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 97.7 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 25.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
Home Health Aides | 4.3 |
Counselors | 1 |
Medical Social Workers | 0.8 |
Registered Nurses | 2.46 |
Other Personnel | 0.5 |
Total Employees | 9.06 |
---|
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
Others | 0.2 |
Total Volunteers | 0.2 |
---|
News Archive
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
People in the industrialized counties are getting older and are very often in good health as a result of good nutrition, a healthier lifestyle and a higher level of education. More people nowadays know how to keep fit and prevent diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
› Verified 4 days ago
Aspirus At Home Location: 311 Sixth Street, Calumet, Michigan, 49913 Phone: (906) 337-5700 |